Colorado will receive part of a $49.2 million judgment against Pfizer to resolve allegations that the drug company unlawfully promoted two of its medications.
“The state will receive more than $1.125 million for future consumer protection efforts.
“When it comes to something as important as people’s health, it is imperative that consumers receive accurate information,” said Attorney General John Suthers. “We cannot tolerate unsubstantiated claims about drug benefits.
The AGs in 32 states claim that Pfizer engaged in unfair and deceptive practices in its promotion of Zyvox and Lyrica by making misleading and unsubstantiated superiority claims that broadened the indication for the antibacterial agent approved to treat certain types of infections.
Pfizer agreed to reform how it promotes the drug.